|
Authors
|
Voit, B.
|
|
Title
|
How can chronic lymphocytic leukemia be treated effectively in a variety of patients?
|
|
Date
|
21.06.2016
|
|
Number
|
52363
|
|
Abstract
|
One the most common types of leukemia is chronic lymphocytic leukemia. To find the right treatment for an individual patient with that disease is a challenging task and many patients develop a resistance against the existing drugs. The purpose of the research presented by BRIGITTE VOIT in this video is to find new drugs that reduce cancer cells while not destroying other cells in the body. The researchers created two versions of organic molecules called dendrimers, differentiated by type of shell, and compared their effect to that of the commercial drug Fludarabine. The findings are highly relevant for treatment of leukemia: Both types of dendrimers destroy leukemia cells but one of them is more active against cancer cells and at the same time less harmful for healthy cells than Fludarabine. Moreover, the dendrimers have an effect on leukemia cells that are resistant to commonly used treatments.
|
|
Publisher
|
Latest Thinking (lt.org)
|
|
Wikidata
|
|
|
Citation
|
Latest Thinking (lt.org) (2016) Video
|
|
DOI
|
https://lt.org/publication/how-can-chronic-lymphocytic-leukemia-be-treated-effectively-variety-patients
|
|
Tags
|
|
